Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 148 clinical trials for: 150 miles

Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  • Recruiting
NCT06641466
Sex: Female
Age: 18 - 45
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
  • Recruiting
NCT06616194
Sex: All
Age: 12 - 17
Locations: 50
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  • Recruiting
NCT04649242
Sex: All
Age: 6 - 17
Locations: 231
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
  • Recruiting
NCT05355701
Sex: All
Age: 16+
Locations: 40
View study
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
  • Recruiting
NCT05261139
Sex: All
Age: Up to 17
Locations: 73
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
  • Recruiting
NCT06991257
Sex: All
Age: 18+
Locations: 24
View study
Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
  • Recruiting
NCT07029828
Sex: All
Age: 6 - 14
Locations: 4
View study
Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
  • Recruiting
NCT06760637
Sex: All
Age: 18+
Locations: 452
View study
Recruiting
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
  • Recruiting
NCT05070845
Sex: All
Age: 18 - 70
Locations: 28
View study
...